Market Overview 

In 2024, the fill-finish manufacturing industry produced revenue of USD 11.1 billion, which will touch USD 20.7 billion by the end of the decade, growing at 10.9% CAGR during the projection period, propelled by the increasing demand for injectables, including biologics and customized medicines.  

This procedure has a substantial role in the making procedure of medicinal and biotechnology sectors since this step is the final step where biologic and synthetic medications are poured onto their containers and then packed for distribution drives. There has been innovation in the fill−finish procedures by using modern tech in areas like speed, precision, and output. Technical improvement has landed in the manufacturing processes where intricate machines have replaced manual labor.  

Automated systems can manage several activities with high accuracy and efficiency making it difficult for the systems to make mistakes and increase productivity. This is achieved through the applied robotics; vial filling and stoppering, capping, and labeling, which makes operations more standardized.  

This not only facilitates the process but also contributes to the cleanliness of the finished good, in addition to breeding its quality. However, single-use systems are emerging in the fill-finish manufacturing market due to the following reasons List several benefits of single-use systems: These systems are the bags, tubing, filters, and connectors which are designed to be used once through the entire manufacturing process and then discarded.  

Key Insights 

  • In 2023, the consumables category held the largest market share at 65% and is expected to maintain its dominance. 

  • Consumables in the fill−finish process include single-use items like vials, syringes, cartridges, stoppers, caps, seals, and filters. 

  • The trend of using single-use consumables is driven by the need to reduce cross-infection risk, achieve faster changeovers, and minimize capital investments and maintenance costs. 

  • The demand for consumables has increased significantly, boosting their market share in the fill−finish manufacturing sector. 

  • The consumables category benefits from a wide range of suppliers and producers offering customized solutions for pharmaceutical and biotech manufacturers. 

  • A competitive landscape ensures a regular supply of innovative and efficient consumables resistant to infections. 

  • Consumables are crucial for maintaining the sterility and quality of injectable drugs, and meeting strict regulatory and product quality requirements. 

  • Prefilled vials, syringes, and other consumables undergo rigorous testing to ensure compatibility with various drug formulations and maintain drug stability and efficacy. 

  • The importance of high-quality consumables in ensuring the safety and efficacy of injectable drugs contributes to their significant market share. 

  • In 2023, the APAC region held the largest industry share at approximately 45% and is projected to maintain its dominance. 

  • It is also rapidly developing as pharmaceuticals and biotechnology region in some countries such as China, Indian, Japan and South Korea.  

  • These countries have strong or developing frameworks of a pharmaceutical industry, many qualified employees, and suitable regulations from the authorities. 

  • As is evidenced with many of North Americas and Europes pharma and biotech companies, the end-stage production process in particular is being out sourced to firms in the Asia-Pacific.  

  • Increase in the population and health care cost in Asia-Pacific area is a key reason to call for pharmaceutical products such as injectable drugs.  

  • Increasing income levels and better health care facilities in the region are driving the need for new generation treatments and injectables. 

 

Source: P&S Intelligence